Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

1.02
-0.0450-4.23%
Post-market: 1.040.0200+1.96%17:35 EDT
Volume:4.86M
Turnover:5.02M
Market Cap:73.92M
PE:-1.59
High:1.10
Open:1.04
Low:0.9600
Close:1.07
52wk High:1.55
52wk Low:0.1952
Shares:72.47M
Float Shares:58.06M
Volume Ratio:0.22
T/O Rate:8.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6401
EPS(LYR):-0.7437
ROE:-543.97%
ROA:-70.59%
PB:-20.65
PE(LYR):-1.37

Loading ...

PDS Biotech sets 2026 annual shareholder meeting

Reuters
·
Jun 15

New fund name, ASX code, investment manager and PDS-V1A

Reuters
·
Jun 05

New Issue 175 Single Stock MINIs Issue Date 4 Jun 26 PDS-CTW

Reuters
·
Jun 03

PDS Biotech regains Nasdaq compliance after shares close above $1 bid threshold

Reuters
·
Jun 03

Lion Active ETF - PDS-ROA

Reuters
·
Jun 01

CitiFirst Commodity MINIs Issue Date 27 May 2026 PDS-CTW

Reuters
·
May 26

PDS Biotechnology Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Analysts’ Top Healthcare Picks: Verastem (VSTM), PDS Biotechnology (PDSB)

TIPRANKS
·
May 13

PDS Biotechnology Q1 net loss narrows

Reuters
·
May 13

PDS Biotechnology Q1 EPS USD -0.13

THOMSON REUTERS
·
May 13

PDS Biotechnology Q1 Net Income USD -7.3 Million

THOMSON REUTERS
·
May 13

PDS Biotechnology Corp expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
May 11

Platinum Active ETFs SPDS and Platinum Trust PDS-PAX

Reuters
·
May 11

PDS Biotech schedules first-quarter results conference call, webcast

Reuters
·
May 06

PDS Biotech signs USD 6 million promissory note financing with YA II PN

Reuters
·
May 02

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

Analysts’ Top Healthcare Picks: PTC Therapeutics (PTCT), PDS Biotechnology (PDSB)

TIPRANKS
·
Apr 16

PDS Biotechnology announces positive Phase 2 trial data for PDS01ADC

TIPRANKS
·
Apr 15

BUZZ-PDS Biotech jumps on early data for experimental colon cancer drug

Reuters
·
Apr 15

PDS Biotech reports 78% response rate in interim Phase 2 colorectal cancer trial

Reuters
·
Apr 15